Sign Up Today and Learn More About DoubleRainbow Biosciences Stock

Invest in or calculate the value of your shares in DoubleRainbow Biosciences or other pre-IPO companies through EquityZen's platform.

Get Started

DoubleRainbow Biosciences Stock

DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry.

About DoubleRainbow Biosciences Stock




Cambridge, MA, US

DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry from the natural world to benefit people’s lives. Rooted in the mechanistic understanding of specialized metabolic systems in plants and other organisms, we devise novel biosynthetic strategies that provide sustainable access to high-value natural products of medicinal or industrial significance. Inspired by the evolutionary principles underlying natural metabolic systems, it further expands the chemical space beyond what nature offers. Leveraging ancient wisdom distilled into the world’s traditional herbal medicines and a deep knowledge base of modern disease biology, it develops nature-inspired new medicines for treating human diseases.

DoubleRainbow Biosciences Press Mentions

Stay in the know about the latest news on DoubleRainbow Biosciences

DoubleRainbow Biosciences Management

Leadership team at DoubleRainbow Biosciences


Tian Xu

Chief of Staff and Senior Director of Business Development

Kevin O’Driscoll

Locked Features

Join now and verify your accreditation status to gain access to:

  • DoubleRainbow Biosciences current valuation
  • DoubleRainbow Biosciences stock price
  • Available deals in DoubleRainbow Biosciences and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in DoubleRainbow Biosciences stock?

Accredited investors can buy pre-IPO stock in companies like DoubleRainbow Biosciences through EquityZen funds. These investments are made available by existing DoubleRainbow Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell DoubleRainbow Biosciences stock?

Shareholders can sell their DoubleRainbow Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."